Atlas Trials

Safety and Efficacy Study of Mesenchymal Stem Cell in Treating Kidney Fibrosis

Clinical trial NCT03460223 · UNKNOWN

Trial details

NCT number
NCT03460223
Sponsor
Nanjing Medical University
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Renal Cirrhosis
Start date
2018-04-01
Primary completion
2020-03-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.